Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer
Clinical trial NCT04675866 · UNKNOWN
Trial details
- NCT number
- NCT04675866
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-17
- Primary completion
- 2023-12-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.